Kolumne, ORE

Original-Research: Rosenbauer International AG - von NuWays AG Einstufung von NuWays AG zu Rosenbauer International AG Unternehmen: Rosenbauer International AG ISIN: AT0000922554 Anlass der Studie: 5-pager Empfehlung: BUY seit: 12.01.2024 Kursziel: EUR 54.00 Kursziel auf Sicht von: 12 Monaten Letzte Ratingänderung: Analyst: Christian Sandherr Rosenbauer is back on track with a record high in order intake Caused by supply chain issues and raw material price inflation, Rosenbauer's operating result turned negative during FY'22.

12.01.2024 - 09:01:35

Original-Research: Rosenbauer International AG (von NuWays AG): BUY


Original-Research: Rosenbauer International AG - von NuWays AG

Einstufung von NuWays AG zu Rosenbauer International AG

Unternehmen: Rosenbauer International AG
ISIN: AT0000922554

Anlass der Studie: 5-pager
Empfehlung: BUY
seit: 12.01.2024
Kursziel: EUR 54.00
Kursziel auf Sicht von: 12 Monaten
Letzte Ratingänderung: 
Analyst: Christian Sandherr

Rosenbauer is back on track with a record high in order intake
 
Caused by supply chain issues and raw material price inflation,
Rosenbauer's operating result turned negative during FY'22. However,
Rosenbauer successfully managed the operating turnaround and delivers
positive results again since Q2 2023. Thanks to Rosenbauer having done its
homework and structural trends kicking in, we expect this turnaround to
continue in 2024.
Until 2025e, Rosenbauer should be able to grow sales by 6.9% p.a. (2022-25e
CAGR) to EUR 1.2bn with EBIT margins north of 5% (eNuW 2025: 5.4%) thanks to:
 
Supply chain improvements: During FY'22 chassis lead times of OEMs
deteriorated significantly. Although lead times are still not back at
pre-crisis levels, the situation is noticeable better than in FY'22. For
example, the average MAN chassis lead time decreased from over 18 months in
FY'22 to 10-12 months in FY'23. However there is no further material
improvement of delivery times expected at MAN and Daimler in 2024, while
Volvo and Scania should approach pre-crisis levels.
 
Significant price increases: Rosenbauer raised its vehicle prices
substantially during FY'23, to account for a higher cost base. The average
price per fire truck in 9M 2023 increased by 9.8% yoy and the average price
per vehicle body increased by 22.7% yoy. Old unprofitable customer
contracts not reflecting the higher cost base are successively leaving the
order book and giving room for a further margin improvement.
 
Structural growth drivers: Global warming for instance causes a severe rise
in natural disasters such as wildfires, storms, and floods which elevates
the demand for firefighting equipment and trucks. Another growth driver is
the electrification of firefighting trucks, supporting the demand for
Rosenbauer's high margin electric models RT (Revolutionary Technology) and
the PANTHER electric.
 
As the supply chain situation further improves and with a record high in
order backlog (9M 2023: EUR 1758m) in the hand, shares look poised for a
re-rating. Furthermore, Rosenbauer is currently examining the issuance of a
hybrid bond to strengthen its balance sheet. A successful issuance could
work as a catalyst, bringing the shares back to its intrinsic value. Hence,
we reiterate our BUY rating with an unchanged EUR 54.00 PT based on DCF.
-continued-

Die vollständige Analyse können Sie hier downloaden:
http://www.more-ir.de/d/28647.pdf
Die Analyse oder weiterführende Informationen zu dieser können Sie hier downloaden
www.nuways-ag.com/research.

Kontakt für Rückfragen
Die Analyse oder weiterführende Informationen zu dieser können Sie hier downloaden
www.nuways-ag.com/research.
Kontakt für Rückfragen
NuWays AG - Equity Research
Web: www.nuways-ag.com
Email: research@nuways-ag.com
LinkedIn: https://www.linkedin.com/company/nuwaysag
Adresse: Mittelweg 16-17, 20148 Hamburg, Germany
++++++++++
Diese Meldung ist keine Anlageberatung oder Aufforderung zum Abschluss bestimmter Börsengeschäfte.
Offenlegung möglicher Interessenskonflikte nach § 85 WpHG beim oben analysierten Unternehmen befinden sich in der vollständigen Analyse.
++++++++++

-------------------übermittelt durch die EQS Group AG.-------------------


Für den Inhalt der Mitteilung bzw. Research ist alleine der Herausgeber bzw. 
Ersteller der Studie verantwortlich. Diese Meldung ist keine Anlageberatung
oder Aufforderung zum Abschluss bestimmter Börsengeschäfte.

@ dpa.de

Weitere Meldungen

Original-Research: Nynomic AG (von Montega AG): Kaufen Original-Research: Nynomic AG - von Montega AG Einstufung von Montega AG zu Nynomic AG Unternehmen: Nynomic AG ISIN: DE000A0MSN11 Anlass der Studie: Update Empfehlung: Kaufen seit: 10.05.2024 Kursziel: 47,00 EUR (zuvor: 48,00 EUR) Kursziel auf Sicht von: 12 Monaten Letzte Ratingänderung: - Analyst: Miguel Lago Mascato Q1: Solider Jahresauftakt - Steigerung der ausgezeichneten H2/23-Performance & M&A-Newsflow erwartet Nynomic hat Mittwoch Q1-Zahlen veröffentlicht, die eine spürbare Steigerung ggü. (Boerse, 10.05.2024 - 16:16) weiterlesen...

Original-Research: MPH Health Care AG (von First Berlin Equity Research GmbH)... Original-Research: MPH Health Care AG - from First Berlin Equity Research GmbH Classification of First Berlin Equity Research GmbH to MPH Health Care AG Company Name: MPH Health Care AG ISIN: DE000A289V03 Reason for the research: Vorläufige Ergebnisse 2023 Recommendation: Kaufen from: 10.05.2024 Target price: EUR81 Target price on sight of: 12 Monate Last rating change: - Analyst: Ellis Acklin First Berlin Equity Research hat ein Research Update zu MPH Health Care AG (ISIN: DE000A289V03) veröffentlicht. (Boerse, 10.05.2024 - 12:41) weiterlesen...

Original-Research: Knaus Tabbert AG (von First Berlin Equity Research GmbH): ... Original-Research: Knaus Tabbert AG - from First Berlin Equity Research GmbH Classification of First Berlin Equity Research GmbH to Knaus Tabbert AG Company Name: Knaus Tabbert AG ISIN: DE000A2YN504 Reason for the research: Dreimonatsbericht Recommendation: Kaufen from: 10.05.2024 Target price: EUR86 Target price on sight of: 12 Monate Last rating change: - Analyst: Ellis Acklin First Berlin Equity Research hat ein Research Update zu Knaus Tabbert AG (ISIN: DE000A2YN504) veröffentlicht. (Boerse, 10.05.2024 - 11:46) weiterlesen...

Original-Research: ZEAL Network SE (von NuWays AG): Kaufen Original-Research: ZEAL Network SE - from NuWays AG Classification of NuWays AG to ZEAL Network SE Company Name: ZEAL Network SE ISIN: DE000ZEAL241 Reason for the research: Recommendation: Kaufen from: 10.05.2024 Target price: EUR 53.00 Target price on sight of: 12 Monaten Last rating change: Analyst: Henry Wendisch Staggering Q1 kicks off new growth phase; chg est. (Boerse, 10.05.2024 - 09:07) weiterlesen...

Original-Research: Nynomic AG (von NuWays AG): Kaufen Original-Research: Nynomic AG - from NuWays AG Classification of NuWays AG to Nynomic AG Company Name: Nynomic AG ISIN: DE000A0MSN11 Reason for the research: Update Recommendation: Kaufen from: 10.05.2024 Target price: EUR 52.00 Target price on sight of: 12 Monaten Last rating change: Analyst: Christian Sandherr Solid start into FY24 despite challenging end markets Topic: Nynomic published a solid start into the year with order intake returning to growth for the first time since Q3 2022. (Boerse, 10.05.2024 - 09:06) weiterlesen...

Original-Research: R. STAHL AG (von NuWays AG): Kaufen. STAHL AG - from NuWays AG Classification of NuWays AG to R. Original-Research: R. (Boerse, 10.05.2024 - 09:02) weiterlesen...